Demand on your CARE: Medication Management for Older Adults
Medication management is one of the major tasks in elder care. Empowering both older adults and caregivers with essential skills to ensure safe and effective medication usage is crucial. Taking this course will help you understand the common challenges of medication management in older adults, strategies for improving medication adherence and medication safety.
Chapter 1
Chapter 1 - Common Challenges of Medication Management in Older Adults
No matter you are a formal caregiver who takes care of your older person, or you are a family caregiver who looks after your beloved family member, have you come across the below challenges on using medication in older adults?
- adverse drug effects
- self-adjustment on the dosage of the medication
- medication refusal
- poor medication adherence
- medication errors
- improper supplement and medication use
Let's watch the below videos to see if they are the real stories around you!
1. Adverse Drug Reactions in Older Adults
2. Dealing with Medication Refusal in Dementia Care
3. Improving Medication Adherence in Older Adults
4. Enhancing Medication Safety in Elderly Homes
5. Potential Risk of Self-medication
After watching the videos, can you guess how's the actual situation of medication use among older adults in Hong Kong?
How many older people suffer from chronic diseases and require long-term medication?
Do they have adequate knowledge about their medication?
Can they take the medication properly on their own?
Do they consult a doctor or seek help from pharmacist when they have questions about the medication?
Try to find the answer here.
Now you should know why learning the medication management in older adults is important. Let's start the course to understand more about medication management in older adults.
Introduction
With the increased in elderly population in HK affected by multiple chronic diseases, the likelihood of increased medication use rises proportionally.
The prevalence of drug use increases with age.
Older adults are largest consumer of health supplements and over-the-counter medications.
High prevalence of older adults using Chinese medicine.
Age Related Changes Related to Medication Management
Medications work differently in older adults.
Do you know how age-related changes affecting the action of medication when going into the older adult's body?
Pharmacokinetics (PK) - is the study of the changes in the absorption, distribution, metabolism and excretion of drugs in the body over time, and the quantification and prediction of the concentration, distribution and effects of drugs in the body.
Absorption:
Age related changes do not seem to have significant effect on drug absorption.
Distribution:
It refers to where the drug goes after it enters the blood stream.
As a consequence of decreased total body water, drugs that are predominantly confined to the water compartment tend to have smaller volume of distribution.
Decreased albumin level is common in malnutrition and reduction in protein binding may contribute to increased free drug level and hence its toxic effects e.g. phenytoin toxicity can occur in frail elderly with hypoalbuminemia even total serum drug level is not high.
Metabolism:
Drug clearance by liver depends on the liver blood flow.
Impaired liver blood flow may affect metabolism of drugs depending on liver metabolism e.g. propranolol, verapamil etc.
Hepatic clearance also reduced due to reduction of liver enzyme (cytochrome p450).
Dosage adjustment is needed in patients with liver function impairment.
Elimination:
Due to reduction in kidney function (glomerular filtration rate- GFR), even in the absence of kidney disease, GFR may reduce by 35 to 50% in older adults.
Drugs heavily dependent on renal clearance include digoxin, aminoglycosides, angiotensin-converting-enzyme inhibitors (ACEi) and diuretics.
Altered Pharmacodynamics
Different drugs have specific pharmacological mechanisms of action in the body.
The ageing process may induce more or less sensitivity to specific medications through changes in the no. of receptors, affinity to receptors and /or post-receptor responses.
Older adults are prone to the unwanted effects of cardiovascular and CNS drugs.
Common Adverse Drug Reactions (ADRs) in Older Adults
Increased ADRs With Age
ADRs are defined as any noxious, unintended, and undesired effects of a drug, excluding therapeutic failures, intentional and accidental poisoning and drug abuse.
ADRs that result in hospital admissions are usually dose dependent and can be predicted by understanding the drug actions e.g. NSAID leading to GIB.
In a study of 513 patients, in hospital ADRs were found in 135 patients:
Acute kidney injury/electrolyte disturbance due to diuretics (25%)
Falls due to benzodiazepine (18%)
Acute confusion/falls/sedation/constipation due to opiates (18%)
Bradycardia due to beta blockers (9%)
In a large cross-sectional study, 4 medications implicated alone or in combination with hospitalization were:
Warfarin (33%)
Insulins (13.9%)
Anti-platelet agents (13.3%)
Oral hypoglycaemic agent (10.7%)
Prescribing Cascade
A prescribing cascade happens when a side effect of one medication is mistaken for a new medical condition and is treated with another medication.
It can increase the risk of having more side effects and drug interactions.
Polypharmacy increases the possibility of a "prescribing cascade".
Examples of prescribing cascade is shown in below table:
Drug-disease Interactions
Cardiovascular drugs and cardiac diseases
Bradycardia is common in older adults due to conduction defect.
Can be orientated by drugs that slow heart rate e.g. beta-blockers digoxin, some Ca channel blockers, or combinations of these drugs.
Digoxin has a narrow therapeutic window and is renally excreted. In the older adults, digoxin toxicity is more frequent due to prevalence of renal impairment.
Anticholinergic drugs and cognitive impairment
Patients with cognitive impairment or dementia are more susceptible to drugs that affect the brain, leading to delirium.
These include anti-cholinergic drugs or drugs with such properties.
E.g. older generations of antihistamines, dopamine agonists, antipsychotics, tricyclic antidepressants, artane, oxybutynin, tolterodine, steroids…...
Narcotics
Narcotics given to older people with dementia can lead to delirium.
DM drugs
SGLT2 inhibitors may lead to increased risk of ketoacidosis if patient is suffering from dehydration due to acute illness e.g., Gastroenteritis with diarrhoea and reduced appetite.
Hence, we need to educate patient to withhold SGLT2 inhibitors if they are suffering from acute illnesses.
Drug-drug Interactions
Cardiovascular system
All drugs that slow heart rate can potentiate the problem.
E.g. combination of betablockers (metoprolol, propranolol, atenolol) with digoxin or some Ca channel blockers
Acute renal failure may occur if ACEi is added to a diuretic which the patient is already dehydrated or has impaired renal function.
➜ The dose of diuretics needs to be reduced before adding ACEi. Monitoring of RFT is important.
Combination of anti-HT may lead to lowish BP or postural hypotension.
➜ Careful monitoring and titration are needed. Start low and go slow is important.
Electrolyte disturbances
Hyperkalaemia may occur if ACEi is given together with aldactone or amiloride.
Hypokalaemia is common after given diuretics and if given digoxin or amiodarone, arrhythmia may occur.
Central nervous system
Antiepileptics ➜ potentiate the sedative effect of hypnosedative.
Tricyclic antidepressants (TCA) ➜ potentiate the sedative effect of antiepileptics.
Gabapentin or Lyrica ➜ cause more drowsiness when use with other antipsychotics.
Bupropion ➜ cause serotonin syndrome if tramadol is given together.
Anticoagulant and other drugs
The anti-coagulant effect of warfarin, novel oral anticoagulants (NOACs) can be potentiated by aspirin, NSAID, and other anti-platelet drugs like Plavix.
Warfarin effect can be affected by antibiotics.
Polypharmacy in Older Adults
The term polypharmacy lacks universally consistent definition.
Most define either qualitatively as the use of more than necessary and or inappropriate medications.
Some define quantitatively the regular use of 5 or more medications.
The provision of guideline-adherent medical care increasingly means the addition of more medications to reach disease specific targets, but this is at the risk of exposing an older adult to multiple drug-drug and drug-disease interactions.
Polypharmacy has been linked to poor outcomes e.g. falls, hospitalizations, frailty etc.
Type 2 Diabetes Mellitus Is a Polypharmacy Condition
Glycaemic control*
Cholesterol control*
BP control*
Neuropathy drugs
Aspirin
Non-DM drugs
* Use different drugs with different mechanisms of action to achieve treatment goals
Potentially Inappropriate Prescriptions
It is defined as a therapy whose adverse risks exceed its health benefits.
Inappropriate medication is a major cause of ADRs in older patients. It is also associated with increased risks of falls, hospital admissions and death.
A local study in an extended hospital shows 52% of patients were discharged with one or more inappropriate drugs.
The most common inappropriate drugs are those for respiratory and GI systems.
The commonest reasons for inappropriateness were:
drug with no apparent indication
inappropriate dose, frequency or duration
use of duplicate drugs
use of contraindicated drugs
Clinical Tools to Combat Polypharmacy and Reduce Inappropriate Prescriptions
Use a Delphi consensus among geriatric and pharmacology experts who analyzed databases of frail, elderly nursing home residents in the US to identify potentially inappropriate medications.
The latest Beers criteria were developed by AGS in 2015. It comprised of 5 sub-lists of medications that should be avoided in elderly.
Limitations
Not applicable to palliative and hospice care because of the shift in benefit-to harm ratio in EOL decisions.
START – consists of 22 evidence based prescribing indicators for commonly encountered diseases in older people and addresses errors such as the omission of drug therapy likely to be beneficial to patients.
STOPP – consists of 65 clinically significant criteria for potentially inappropriate prescriptions in older people and is classified according to physiological systems.
STOPP/START significantly improved medication appropriateness in acute hospital.
If applied within 72 hrs of admission, it reduces ADRs and shortened length of stay (LOS).
Drug Compliance and Adherence
What is the difference between "drug compliance" and "drug adherence"?
Compliance means the patients follow and comply with the doctor's prescription passively.
Adherence means the informed patient will stick to taking their recommended treatment.
It was estimated that adherence rates for prescribed medications are only about 50% in USA.
We usually use the term "medication adherence" nowadays.
Types of non-adherence
Intentional non-adherence
It is the active decision occurring when the patient perceives a low health risk of an illness or has doubts about the drug benefit and or safety.
The characteristics of intentional non-adherence are:
Recognition / anticipation of side effects
Fears of prescribing errors
Lack of faith in the prescriber
Failure to accept diagnosis
Fears of addiction
Dislike for taking medicines
Perception of health risk
Testing medicines against symptoms
Unintentional non-adherence
It is the passive process whereby patients fail to adhere to prescribing instructions through forgetfulness, carelessness, or circumstances out of their control e.g. acute illnesses.
The characteristics of unintentional non-adherent medication taking behaviour are:
Forgetfulness
Lifestyle change
Disruption of daily regimen
Period of illness
Drug related memory loss
Being asymptomatic
Dealing with non-adherence
Open discussion is always encouraged to address the reason for non-adherence.
Strategies to improve adherence based on Cochrane system review
Simplify drug regimen
More thorough patient instruction and counselling
Reminders
Closer follow- up
Couple focused therapy
Psychological therapy
Crisis intervention
Manual telephone follow-up
Polypharmacy and drug non-adherence are the common medication issues among older adults. No matter a formal caregiver or family caregiver, we always encourage them to communicate with the doctors actively about their difficulties in managing the medication with the older adults. The doctor may consider "deprescribing".
Deprescribing
Inappropriate prescribing and polypharmacy in older persons are associated with increased risks of falls, adverse drug reactions, hospital admissions, and death.
Deprescribing is the process of tapering, stopping, discontinuing, or withdrawing drugs, with the goal of managing polypharmacy and improving outcomes.
Deprescribing can improve adherence, cost, and health outcomes but may have adverse drug withdrawal effects.
Difficulties in deprescribing
It is apparent that deprescribing in older persons likely results in reduced medication usage and cost and is unlikely to cause harm to patients.
However, there is a lack of high-quality, long-term, prospective evidence to show that deprescribing results in clinically meaningful outcomes.
For example:
Mortality not reduced in recent randomized control trial.
Deprescribing has been shown to reduce the number of falls, but not to change the risk of having the first fall.
It is suggested that the absence in a change is a positive outcome as the medications can often be safely withdrawn without altering health outcomes.
Guideline for deprescribe
The current body of evidence yields little guidance for practitioners on exactly how to deprescribe.
In people with multiple long-term conditions and polypharmacy deprescribing represents a complex challenge as clinical guidelines are usually developed for single conditions.
In these cases, tools and guidelines like the Beers Criteria and STOPP/START could be used safely by clinicians.
Risk of deprescribe
It is possible for the patient to develop adverse drug withdrawal events (ADWE). These symptoms may be related to the original reason why the medication was prescribed, to withdrawal symptoms or to underlying diseases that have been masked by medications.
For some medications, ADWEs can generally be minimized or avoided by tapering the dose slowly and carefully monitoring for symptoms.
Doctors should be aware of which medications usually require tapering (such as corticosteroids and benzodiazepines), and which can be safely stopped suddenly (such as antibiotics and nonsteroidal anti-inflammatory drugs).
Resources to support deprescribing
Implicit tool
The CEASE algorithm to prompt clinicians to consider if the treated condition remains a current concern for their patient.
The ERASE algorithm prompts clinicians to consider if the treated condition is still requiring treatment. ERASE mnemonic stands for "evaluate diagnostic parameters", "resolved conditions", "ageing normally", "select targets" and "eliminate".
Explicit tool
The Beers Criteria and the STOPP/START criteria.
Apart from the above issues, is that safe for the older adults to take both Western and Chinese medicine together? Are there any precautions?
Concomitant Use of Complementary Medicine
Frequently overlooked issue is the use of complementary medicine in Chinese people.
¾ of the older adults take complementary medicine in the form of over-the-counter nutraceuticals, herbal or traditional Chinese medications, often in conjunction with, or as an alternative to, prescribed Western medicine.
Adverse drug interactions including herb-drug interactions and drug adherence issues may arise as a result.
Use of Chinese medicine in HK
In 2007, a local study of 31762 non-institutionalized and institutionalized residents, among those reporting symptoms of medical problems in the 30 days preceding the survey:
1.8% had used TCM regularly in past 6 months.
8.8% had consulted a TCM practitioner.
2.7% had used OTC TCM products.
Another local study in 2001 showed widespread use of OTC drugs, health food and TCM in addition to prescription western medicines were noted in 285 community dwelling older people in Hong Kong West.
Proprietary Chinese medicines (PCM)
PCM refer to proprietary products composed solely of Chinese herbal medicines or any materials of herbal, animal or mineral origin, used as active ingredients, that are formulated in a finished dose form.
Use of PCM is common in HK. It can be obtained in community pharmacies, Chinese medicine practitioners, or from mainland China.
In a review in 2011 on patients admitted to hospital due to ADRs secondary to PCM, the causes of ADRs are:
Adulteration of the PCM
Misuse by the consumer
Misuse by the prescriber
Drug allergies
Toxicity related to use of TCM/PCM
They are uncommon in clinical practice.
Most dangerous ADR is dysrhythmia following herbs containing aconitum alkaloids such as Radix Aconiti (Chuan Wu), Radix Aconiti Kusnezoffii (Cao Wu) and Radix Aconiti Lateralis Preparata (Fu Zi). These herbs are commonly prescribed for musculoskeletal pain.
Herb induced liver injury (HILI)
Many herbs have been reported to cause hepatotoxicity.
A local study showed 9 probably cases were identified among 99 cases admitted to local hospitals for suspected HILI from 2011 to 2013.
The causes of HILI can be idiosyncratic responses or dose response.
TCM contaminated by anticholinergic herbs
When using TCM together with western medicine
Both western doctors and Chinese medicine practitioners should ask carefully what drugs (western medicine and TCM) the patients are taking currently.
Anti-coagulant like warfarin should be noted as TCM may interact with warfarin, leading to under or over warfarinization.
In general, the advice is not to take the TCM and western drugs at the same time.
Suggest spacing out the TCM and western medicine at least 2 to 3 hrs.
Further information for your interest to explore how a doctor prescribe medication to an older adult. What are the considerations?
Clinical Approach When Prescribing
To obtain a satisfactory history of drug use, and to assist in identifying adverse drug reactions and potential interactions, the following can be considered:
Adherence
Is he taking the medications? Any drugs left in his pill box?
How is he taking the drugs? (frequency, dosage etc.)
Does he often forget to take the drugs? Has he got cognitive impairment? If yes, does he live with someone who can supervise medications?
Polypharmacy
How many drugs is he taking including the prescribed drugs, Chinese medicine and OTC medications e.g. vitamins? (Please bear in mind the patient may not volunteer the information unless being asked specifically.)
Ask patients to bring to you all the medications they are taking to review in the clinic.
Check patient history and drug information in eHealth.
Even if he is on relatively few drugs, it is important to assess if the indications are current and appropriate.
Consider deprescribe when there is polypharmacy.
Review potential drug-drug interactions
Review any chance of potential drug-drug interactions.
Review any symptoms caused by drugs
For example
Delirium caused by anti-cholinergic drugs – if so, remove the culprit drug rather than adding anti-psychotic to control delirium.
Dizziness due to postural hypotension caused by alpha blocker.
Syncope due to bradycardia caused by beta-blocker plus Ca channel blocker.
The list goes on and on……………
Remember atypical presentation of older adult is common. You may refer to MOOC 14 Chapter 3 about atypical presentation.
Some more hints and considerations
Are there any known drug allergies?
Be aware of non-pharmacological treatment options.
Be aware of age-related changes in pharmacokinetics and pharmacodynamics.
Encourage self-management plan.
Involve the patient or carers in the treatment plan to improve compliance.
Physical examinations
General examination
Some examples of specific examination:
- Check for postural hypotension.
- Check for gait disturbance.
Especially for patients on anti-psychotics, anti-depressant
- Mental state.
Any delirium due to drug side effects?
- Constipation leading to abdominal pain and distension.
Can be due to narcotics, anti-cholinergic, Calcium, Iron supplements.
- Look for skin rash due to drug allergies.
- Check for pallor (anaemia) due to use of NSAID or NOAC.
Investigations
Renal function test (Na, Ka, urea, creatinine) is perhaps the most important test.
Many drugs may lead to hyponatremia, hypokalaemia or hyperkalaemia, acute kidney injury with rising creatinine.
Some drugs need to dose adjustment or stopped totally in renal impairment e.g. NOAC, SGLT2 inhibitors.
A better estimation of renal function is eGFR or GFR calculated by serum creatinine, age, weight, and gender (e.g. Cockcroft-Gault equation).
Liver function test
New abnormality in LFT may imply drug induced toxicity as many drugs are metabolized by liver.
Drug toxicity may conversely be due to pre-existing liver disease causing reduced drug metabolism and clearance.
Thyroid function test
Drugs like amiodarone may cause thyroid dysfunction.
CBP
Drugs like warfarin, aspirin, NOAC etc may lead to anaemia due to increase bleeding tendency e.g. in GI tract.
INR
Monitor warfarin.
Serum drug levels
Drugs like anti-epileptics, digoxin, certain antibiotics e.g. vancomycin.
Strategies in Drug Prescription
Weigh up against harm (benefit/harm ratio).
Is the drug necessary?
Is there safer alternative?
Start low and go slow.
Given the variability of pharmacokinetics and pharmacodynamics, the dosage increment should be cautious, balancing the need for an efficacious dose with patient tolerance of the drug.
Dose adjustment for renal, hepatic impairment and frailty
The adjustment must be individualized. As a general guide, a dosage reduction of 30 to 40% is required in older adults.
Special Considerations in Ward Setting in Drug Prescription
Obtain history of drug allergies e.g. antibiotic allergies.
Advise patients to inform ward all the drugs they are taking (both HA and private drugs).
If possible, all drugs to be given by ward staff instead of allowing patients to take their own medications in ward to avoid omission or duplication of drug doses.
Avoid PRN regimen for hospitalized elderly patients as many may receive erratic regimens (as judged by staff unfamiliar with the patient condition).
When discharge, ensure patients/formal and informal carers have adequate education and knowledge of the change of drug regimen. In particular, which drugs have been stopped or added.
The common scenario is that patients continue to take the drugs (which have been stopped in ward) after discharge due to lack of communication.
Ensure patients have adequate drugs, especially those newly prescribed, before attending the next OPD follow-up.
Reference
Ali, M. U., Sherifali, D., Fitzpatrick‐Lewis, D., Kenny, M., Lamarche, L., Raina, P., & Mangin, D. (2022). Interventions to address polypharmacy in older adults living with multimorbidity. Canadian Family Physician, 68(7), e215–e226.
https://doi.org/10.46747/cfp.6807e215
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multi1780morbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37–43.
https://doi.org/10.1016/s0140-6736(12)60240-2
Bungard, T. J., Yakiwchuk, E., Foisy, M., & Brocklebank, C. (2011). Drug interactions involving Warfarin: practice tool and practical management tips. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada, 144(1), 21-25.e9.
https://doi.org/10.3821/1913-701x-144.1.21
Campanelli, C. M. (2012). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60(4), 616–631.
https://doi.org/10.1111/j.1532-5415.2012.03923.x
Chan, D. K. Y. (2021). Chan's practical geriatrics, Forth Edition.
Du Vaure, C. B., Ravaud, P., Baron, G., Barnes, C., Gilberg, S., & Boutron, I. (2016). Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open, 6(3), e010119.
https://doi.org/10.1136/bmjopen-2015-010119
Edwards, I. R., & Aronson, J. K. (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356(9237), 1255–1259.
https://doi.org/10.1016/s0140-6736(00)02799-9
Hilmer, S. N., Gnjidic, D., & Couteur, D. G. L. (2012). Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. PubMed, 41(12), 924–928.
https://pubmed.ncbi.nlm.nih.gov/23210113
Hines, L., & Murphy, J. E. (2011). Potentially Harmful Drug–Drug Interactions in the Elderly: A review. American Journal of Geriatric Pharmacotherapy, 9(6), 364–377.
https://doi.org/10.1016/j.amjopharm.2011.10.004
Lam, M. P. Y., & Cheung, B. (2012). The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Review of Clinical Pharmacology, 5(2), 187–197.
https://doi.org/10.1586/ecp.12.6
Lam, T., & Chan, H. (2017). The Hong Kong Geriatrics Society Curriculum in Geriatric Medicine, 2nd edition, Chapter 15 (pp. 114-125). The Hong Kong Geriatrics Society.
Lindblad, C. I., Hanlon, J. T., Gross, C. R., Sloane, R., Pieper, C. F., Hajjar, E. R., Ruby, C. M., Schmader, K. E., & Panel, M. C. (2006). Clinically important drug-disease interactions and their prevalence in older adults. Clinical Therapeutics, 28(8), 1133–1143.
https://doi.org/10.1016/j.clinthera.2006.08.006
Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in elderly people. The Lancet, 370(9582), 185–191.
https://doi.org/10.1016/s0140-6736(07)61092-7
Nobili, A., Garattini, S., & Mannucci, P. M. (2011). Multiple Diseases and Polypharmacy in the elderly: Challenges for the Internist of the third Millennium. Journal of Comorbidity, 1(1), 28–44. https://doi.org/10.15256/joc.2011.1.4
Reeve, E., Gnjidic, D., Long, J. C., & Hilmer, S. N. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254–1268.
https://doi.org/10.1111/bcp.12732
Seppälä, L., Petrovic, M., Ryg, J., Bahat, G., Topinková, E., Szczerbińska, K., Van Der Cammen, T. J. M., Hartikainen, S., İlhan, B., Landi, F., Morrissey, Y., Mair, A., Gutiérrez-Valencia, M., Emmelot‐Vonk, M. H., Mora, M. Á. C., Denkinger, M., Crome, P., Jackson, S., Correa-Pérez, A., . . . Van Der Velde, N. (2021). STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age And Ageing, 50(4), 1189–1199.
https://doi.org/10.1093/ageing/afaa249
Sheppard, J. P., Burt, J., Lown, M., Temple, E., Lowe, R., Fraser, R., Allen, J., Ford, G. A., Heneghan, C., Hobbs, F. D. R., Jowett, S., Kodabuckus, S., Little, P., Mant, J., Mollison, J., Payne, R., Williams, M., Yu, L., & McManus, R. J. (2020). Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older. JAMA, 323(20), 2039.
https://doi.org/10.1001/jama.2020.4871
Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M., & Chaiyakunapruk, N. (2011). Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Medical Genetics, 12(1).
https://doi.org/10.1186/1471-2350-12-118
Woodford, H. J., & Fisher, J. (2019). New horizons in deprescribing for older people. Age And Ageing, 48(6), 768–775.
https://doi.org/10.1093/ageing/afz109
Woodward, M. (2003). Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications. Journal of Pharmacy Practice and Research, 33(4), 323–328.
https://doi.org/10.1002/jppr2003334323
Wong, C. F., Chiu, P. K. C., & Chu, L. W. (2005). Zopiclone withdrawal: an unusual cause of delirium in the elderly. Age And Ageing, 34(5), 526–527.
https://doi.org/10.1093/ageing/afi132
- End of Chapter 1 -
Chapter 2
Chapter 2 - Case Study on Medication Management
In this Chapter, we will discuss the medication management through a few case studies in the following items:
Common medication issues
Adverse drug reactions (ADRs)
Drug-drug interaction (Can be pharmacokinetic or pharmacodynamic)
Strategies for improving drug regime and adherence
Medication errors in institutional setting
Consideration in medical management in dementia person
Let's start!
Common medication issues
Adverse drug reactions (ADRs)
Case 1
A 74-year-old lady, live at home, cared by maid.
Past history: Chronic insomnia, HT, hyperlipidemia, minor stroke.
Admitted to hospital due to urinary tract infection with fever.
15 tables of Zopiclone (bought over the counter) per night for 10 years
Gingo Biloba
No history of TCM taken.
Can you guess WHY?
The answer is Zoplicone withdrawal.
Diagnosis: Zoplicone withdrawal with delirium.
Treatement: Zoplicone resumed and titrate down ➜ Delirium subsided.
Further information:
Lessons to learn
Careful drug history.
Withdrawal symptom may occur if stopping some drugs (e.g. drugs acting on CNS) abruptly.
A high degree of suspicion is needed.
Case 2
A 90-year-old lady, bedbound, ADL dependent with Clinical Frailty Scale 7.
Past history: History of hip fracture and vertebral collapse, esophagitis and hiatus hernia, dementia.
Drug history:
Denosumab 60 mg every 6 months SC
Calcichew 1 tab daily
Lansoprazole 15 mg daily
Senokot 15 mg nocte prn
She was admitted to hospital due to UTI.
Treated with antibiotics but complicated by coffee ground vomiting ➜ Lansoprazole increased to 30 mg QD.
Complained of constipation ➜ Calcichew stopped.
Upon discharge:
Lanzoprazole 30 mg daily
Senokot 15 mg nocte prn
Denosumab 60 mg every 6 months SC
At follow up:
She has nil complaint.
Due for another dose of q6m Denosumab, RLFT and Bone profile recheck.
Diagnosis: Hypocalcaemia due to denosumab in a patient with renal impairment and stopping calcium supplement.
Lessons to learn
Denosumab and hypocalcaemia
Hypocalcemia is a recognized S/E of Denosumab.
Denosumab inhibits osteoclastic bone resorption, leading to hypocalcemia by reducing calcium mobilization from bone into bloodstream.
Risk factor:
Renal impairment
Vitamin D deficiency
Lack of prophylactic supplementation of calcium and/or vitamin D
Case 3
78 years old, male.
Past health: BPH, HT, DM.
Drug history:
Terazosin
Amlodipine
Metformin
Suffered from flu with cough, fever, nasal congestion, running nose.
Seen by GP ➜ Given Panadol, Piriton, nasal decongestion medications.
Complained of abdominal distension and difficult to urinate for 1 day, leakage of small amount of urine continuously.
Diagnosis: acute urinary retention with overflow incontinence, but why?
Causes: Recent use of anti-histamine and decongestant.
Lessons to learn
Examples of important drug-disease interactions
Case 4
76 years old lady received a prescription for Allopurinol from the GOPC for Hyperuricemia.
However, she began to experience serious side effects one month after taking the drug, including head swelling, fever and allergic reactions such as skin rashes.
She was worsened into "Toxic Epidermal Necrolysis", where the skin ulceration, like a severe burns.
She died after two months.
You may read this local news for your information.
Lessons to learn
Carbamazepine (Tegretol) – another drug also needs to check HLA before prescription.
All Asians given carbamazepine should be tested HLA 1502 due to the risk of Steven Johnson Syndrome (SJS) and toxic epidermal necrosis (TEN) as advised by FDA.
Drug-drug interaction (Can be pharmacokinetic or pharmacodynamic)
Pharmacokinetic nature of drug-drug interaction
Effects of one drug on the absorption, distribution, metabolism, or excretion of another drug.
Interactions→ changes in serum drug concentrations → change clinical response.
The most frequent pharmacokinetic drug-drug interactions involve several isoenzymes of the hepatic cytochrome P450 (CYP) and drug transporters e.g. the P-glycoprotein.
Drugs which affect cytochrome p450 isoezymes
Induction of metabolism of one drug by another
Inhibition of metabolism on one drug by another
Case 1
60 years old lady.
Past history: Double valve replacement, on warfarin for many years, aim INR 2.5 to 3 by cardiologist.
Drug history: Lasix, Slow K, Diltiazem
Developed sore throat for 2 days, with exudates over the tonsils, fever+.
Seen by GP ➜ Given Panadol, cough syrup, azithromycin – 5-day course.
Noticed to have nose bleeding and bruising next morning.
Do you know why?
Blood test:
INR >5
Platelet count normal
Hb 12 drop to 9 g/dl
Diagnosis: Warfarin overdose due to drug-drug interaction by macrolides antibiotics.
Lessons to learn
Warfarin and Macrolides
Examples of macrolides antibiotics are azithromycin, clarithromycin, erythromycin.
Macrolides reduce the metabolism and clearance of warfarin ➜ 🡱 levels and effects of warfarin like bleeding.
Case 2
70 years old man.
Known HT, IHD, DM & renal impairment (Creatinine around 100 baseline).
Admitted to ward due to heart failure.
Investigation:
BNP 5000
Echo – shows HFrEF (EF 35%)
Treated with Lasix, Slow K, Acertil, Aldactone, Metaprolol Zok, Aspirin.
Discharge from ward 3 days later, then follow up 3 weeks later in OPD.
No complaint from the patient.
Blood test repeated showing K 6.5, Creatinine 120 (The blood test was not hemolyzed).
ECG SR with peak T waves.
Diagnosis and treatment
Aldactone and ACEi interaction.
Slow K supplements ➜ severe hyperkalaemia.
Patient was admitted to hospital for urgently correcting hyperkalaemia.
Lessons to learn
ACEI and aldactone
ACEI (Acertil, Lisinopril, Ramipril, Enalapril etc) interact with Spironolactone (Aldactone).
Both have potassium increasing effects.
So when adding together, a very high level K may occur.
Close monitoring of K is needed.
Strategies for improving drug regime and adherence
Case 1
80 years old man, walk with stick, live alone.
Past history: HT, Hyperlipidemia, dementia, DM, parkinsonism, BPH.
Seeing different private doctors with drugs:
Aspirin 80 mg daily
Diamicron 80mg om, 40mg pm
Metformin 250 mg tds
Amlodipine 5 mg BD
Prazosin 1 mg tds
Sinemet 25/100 half tab QID
Artane 1 mg bd
Lipitor 10 mg nocte
Patient admitted to hospital due to hyperglycaemia (hstix >20), malaise and polyuria.
Blood test show HbA1c 9.5%, fasting blood sugar 12.
Patient said he frequently forgot to take drugs especially those need to take more than 2 times per day.
He has poor cognitive function with MoCA 5/30 (dementia range).
No one alone to supervise him in taking medications.
Geriatrician was consulted.
If you were the Geriatrician, what are your actions?
Let's consider drug review to simplify the drug regime, referral to community services and use medication tools!
Drugs regimes were modified to limit to QD and BD.
An example of how to modify drug regime to enhance adherence:
Patient was referred to ICDS (Integrated Care and Discharge Support) program with case manager to do home visit to monitor his drug compliance.
Drug box was given to patient by ICDS case manager to enhance adherence.
➜ Patient drug adherence improved & DM control became satisfactory.
Medication errors in institutional setting
Case 1
90 years old lady, bedbound, no relative, live in a small private RCHE without CGAT.
Past history: CVA with vascular dementia, HT, renal impairment but no history of DM.
Clinical Frailty Scale 8.
Dysphagia, requiring puree as diet.
Admitted to acute hospital due to hypoglycemia (Hstix 1.5 in ambulance).
Immediately given D50 injection, put on dextrose infusion to maintain euglycaemia in ward for 3 days.
Toxicology screening showed gliclazide (Diamicron) in blood.
Review history again – patient had no DM and was NOT on any DM drugs.
There were other residents in RCHE on DM drugs but they were not her roommates.
The RCHE staff denied wrong medications given to index patient.
Can you guess what is happening?
Results after thorough investigation:
Contamination of the mortar in RCHE which was used to grind the drug tablets
Mortar for grinding tablets
It was likely that there was Diamicron residue left on the mortar which belonged to other residents. When the staff grinded the tablets of the index resident, the drugs were contaminated by Diamicron residue of the previous residents.
Since the index resident had anorexia of ageing with poor intake, a small amount of Diamicron could lead to florid hypoglycaemia!
It often takes at least a few days for hypoglycaemia to improve as the half-life of Diamicron is prolonged in renal impaired older patients.
The patient hypoglycaemia finally subsided after 3 days in hospital ➜ discharge back to RCHE.
RCHE staff practice was reviewed by CGAT nurses & advised to:
Buy more mortars so that each resident has its own mortar.
Use a paper to hold the drugs during grinding to minimize contamination of the mortar. Staff has to make sure no drug residues are left on the mortar before grinding tablets of other residents.
Outcome
No more drug contamination incident in that RCHE.
Experience is shared with other RCHEs to avoid similar mistakes happening in other RCHEs.
Consideration in medication management in dementia person
Case 1
A 90-year lady with advanced dementia, BPSD and delusional ideas. She always thought her daughter wanted to poison her, so she refused to take oral medications. She had Parkinson disease and Alzheimer's disease. She was on Sinemet 25/100 mg half tab BD and donepezil 5 mg daily.
After discussion with Geriatrician about this problem,
oral Sinemet and donepezil were stopped.
PD drugs change to rotigotine transdermal patch once daily.
Donepezil changes to rivastigmine transdermal patch once daily.
The patient accepted the use of transdermal patch without drug non-adherence. It also reduced carer stress as the daughter did not need to struggle to give oral medicine to patient.
Lessons to learn
We need to understand the situation of each dementia patient.
Personalized approach is needed to overcome the drug management problem in these patients.
Make use of transdermal route (if available) if appropriate for selected patients.
Reference
Ali, M. U., Sherifali, D., Fitzpatrick‐Lewis, D., Kenny, M., Lamarche, L., Raina, P., & Mangin, D. (2022). Interventions to address polypharmacy in older adults living with multimorbidity. Canadian Family Physician, 68(7), e215–e226. https://doi.org/10.46747/cfp.6807e215
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multi1780morbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37–43. https://doi.org/10.1016/s0140-6736(12)60240-2
Bungard, T. J., Yakiwchuk, E., Foisy, M., & Brocklebank, C. (2011). Drug interactions involving Warfarin: practice tool and practical management tips. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada, 144(1), 21-25.e9. https://doi.org/10.3821/1913-701x-144.1.21
Campanelli, C. M. (2012). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60(4), 616–631. https://doi.org/10.1111/j.1532-5415.2012.03923.x
Chan, D. K. Y. (2021). Chan's practical geriatrics, Forth Edition.
Du Vaure, C. B., Ravaud, P., Baron, G., Barnes, C., Gilberg, S., & Boutron, I. (2016). Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open, 6(3), e010119. https://doi.org/10.1136/bmjopen-2015-010119
Edwards, I. R., & Aronson, J. K. (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356(9237), 1255–1259. https://doi.org/10.1016/s0140-6736(00)02799-9
Hilmer, S. N., Gnjidic, D., & Couteur, D. G. L. (2012). Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. PubMed, 41(12), 924–928. https://pubmed.ncbi.nlm.nih.gov/23210113
Hines, L., & Murphy, J. E. (2011). Potentially Harmful Drug–Drug Interactions in the Elderly: A review. American Journal of Geriatric Pharmacotherapy, 9(6), 364–377. https://doi.org/10.1016/j.amjopharm.2011.10.004
Lam, M. P. Y., & Cheung, B. (2012). The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Review of Clinical Pharmacology, 5(2), 187–197. https://doi.org/10.1586/ecp.12.6
Lam, T., & Chan, H. (2017). The Hong Kong Geriatrics Society Curriculum in Geriatric Medicine, 2nd edition, Chapter 15 (pp. 114-125). The Hong Kong Geriatrics Society.
Lindblad, C. I., Hanlon, J. T., Gross, C. R., Sloane, R., Pieper, C. F., Hajjar, E. R., Ruby, C. M., Schmader, K. E., & Panel, M. C. (2006). Clinically important drug-disease interactions and their prevalence in older adults. Clinical Therapeutics, 28(8), 1133–1143. https://doi.org/10.1016/j.clinthera.2006.08.006
Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in elderly people. The Lancet, 370(9582), 185–191. https://doi.org/10.1016/s0140-6736(07)61092-7
Nobili, A., Garattini, S., & Mannucci, P. M. (2011). Multiple Diseases and Polypharmacy in the elderly: Challenges for the Internist of the third Millennium. Journal of Comorbidity, 1(1), 28–44. https://doi.org/10.15256/joc.2011.1.4
Reeve, E., Gnjidic, D., Long, J. C., & Hilmer, S. N. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254–1268. https://doi.org/10.1111/bcp.12732
Seppälä, L., Petrovic, M., Ryg, J., Bahat, G., Topinková, E., Szczerbińska, K., Van Der Cammen, T. J. M., Hartikainen, S., İlhan, B., Landi, F., Morrissey, Y., Mair, A., Gutiérrez-Valencia, M., Emmelot‐Vonk, M. H., Mora, M. Á. C., Denkinger, M., Crome, P., Jackson, S., Correa-Pérez, A., . . . Van Der Velde, N. (2021). STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age And Ageing, 50(4), 1189–1199. https://doi.org/10.1093/ageing/afaa249
Sheppard, J. P., Burt, J., Lown, M., Temple, E., Lowe, R., Fraser, R., Allen, J., Ford, G. A., Heneghan, C., Hobbs, F. D. R., Jowett, S., Kodabuckus, S., Little, P., Mant, J., Mollison, J., Payne, R., Williams, M., Yu, L., & McManus, R. J. (2020). Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older. JAMA, 323(20), 2039. https://doi.org/10.1001/jama.2020.4871
Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M., & Chaiyakunapruk, N. (2011). Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Medical Genetics, 12(1). https://doi.org/10.1186/1471-2350-12-118
Woodford, H. J., & Fisher, J. (2019). New horizons in deprescribing for older people. Age And Ageing, 48(6), 768–775. https://doi.org/10.1093/ageing/afz109
Woodward, M. (2003). Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications. Journal of Pharmacy Practice and Research, 33(4), 323–328. https://doi.org/10.1002/jppr2003334323
Wong, C. F., Chiu, P. K. C., & Chu, L. W. (2005). Zopiclone withdrawal: an unusual cause of delirium in the elderly. Age And Ageing, 34(5), 526–527. https://doi.org/10.1093/ageing/afi132
- End of Chapter 2 -
Chapter 3
Chapter 3 - Medication Safety
Below videos are the basic knowledge about medication use. Do you have such queries before?
3. Understanding Drug Labels
4. How to Take Medication on an Empty Stomach?
5. Can All Medications Be Cut or Crushed?
6. What If I Miss a Dose of Medication?
7. Dietary Restriction When Taking Medication
8. Are Anti-Inflammatory Drugs the Same as Antibiotics?
9. Guidelines for Medication Purchases
10. Is More Supplement Consumption Better?
Proper Storage of Medications
In general,
store medications in a COOL, DRY place away from direct sunlight.
always keep medications in their ORIGINAL containers to maintain proper labelling and dosage information.
do not mix different medications in the same containers.
keep medications out of reach of children and pets to prevent accidental ingestion.
DO NOT store medications in the bathroom or kitchen where heat and humidity levels fluctuate.
DO NOT keep medications in the car.
1. Should Medicines Be Kept in The Refrigerator?
Temperature Considerations
Some medications are sensitive to temperature changes; check the label or consult your pharmacist for specific requirements.
Refrigerate medications as directed, but do not freeze unless specified.
Extreme temperatures (both hot and cold) can affect medication stability.
➜ Improper storage may cause: Loss of therapeutic effects/ Adverse effects
Light Sensitive Medications
Light can cause oxidation, hydrolysis and loss of potency to some medications. This loss can be greatly minimized by protecting from light.
Examples:
Tetracycline Antibiotics: Tetracycline antibiotics, including doxycycline and tetracycline, are highly susceptible to light degradation. When exposed to light, they can become less effective, making them less capable of treating infections.
Isotretinoin: Isotretinoin is a medication used to treat severe acne. It's highly light-sensitive and should be stored in a dark container or packaging to prevent degradation.
Nitroglycerin: Nitroglycerin is used to treat angina (chest pain) and heart conditions. It's stored in dark containers because exposure to light can cause the medication to lose its potency.
Storage tips for light sensitive medications
Always follow the storage instructions provided on the medication label.
Keep light-sensitive medications in their original packaging, as it's designed to protect them from light exposure.
Store these medications in a cool, dry, and dark place. A medicine cabinet or a drawer is often a suitable location.
Check the medication's appearance and ask your pharmacist if you suspect light-induced degradation.
Medication Specific Storage
Insulin:
Unopened insulin to be stored in the fridge until expiration date;
Opened insulin to be stored in the fridge or under room temperature and use within 28 days.
Eye drops:
Store in a cool place, and some may require refrigeration after opening.
Oral liquids/Suspension:
Some may require refrigeration; others can be stored at room temperature.
Inhalers:
Keep away from direct heat or sunlight.
Childproofing Medications
Use Childproof Caps: These caps are designed to be difficult for young children to open, reducing the risk of accidental ingestion.
Lockable Medication Cabinets: Consider installing lockable medicine cabinets at home, especially in the bathroom.
High Shelves or Storage: Store medications on high shelves or in places that are difficult for children to access.
Educate Children: Educate older children about the potential dangers of medications and the importance of not taking medication without supervision.
Reference: "Medicine Safety: A Key Part of Child-proofing Your Home", Safe Kids Worldwide 2019
Expiration of Medications
Factors Affecting Medication Expiry
Chemical Stability: Medications degrade over time, which can result in a decrease in potency. This degradation is influenced by the chemical stability of the active ingredients.
Packaging: The type of packaging and how well it seals out moisture, light, and air plays a significant role in how long a medication remains potent.
Storage Conditions: Medications stored in proper conditions are more likely to last longer. Exposure to heat, humidity, and light can accelerate degradation.
Identifying Expired Medications
Check the Expiration Date: The expiration date is printed on the medication packaging. It indicates the date until which the manufacturer guarantees the medication's full potency and safety.
Observe Changes in Appearance: Some medications change in color, texture, or odor when they expire. Any noticeable changes may indicate that the medication is no longer safe or effective.
Consult a Pharmacist: If you are uncertain about a medication's status, consult your pharmacist. They can offer guidance and assess whether a medication is still safe to use.
Safe Medication Disposal
Do Not Flush: Avoid flushing medications down the toilet or drain. This can contaminate the water supply.
Medication Recycle Programs: Junior Chamber International Tai Ping Shan and Mannings joint program of "Safe Disposal of Unused Medicines - 藥「勿」胡亂棄", providing a safe and environmentally friendly way to dispose of unused or expired medications.
Mixing with Unwanted Substances: Mix the medication with an undesirable substance (e.g., used coffee grounds or kitty litter) in a sealed container before disposing of it in the trash. This helps deter misuse.
Remove Personal Information:Before disposing of medication containers, remove or obscure any personal information to protect privacy.
2. How to Handle Expired Medications?
Improving Medication Safety
1. Technology
Electronic Health Records 醫健通 (eHealth)
Electronic Health Records (EHR) are digital versions of patient health records that offer comprehensive and real-time information about a patient's medical history, diagnoses, medications, and treatment plans.
It improves medication safety by providing healthcare providers with accurate and up-to-date patient information, allowing for better-informed decisions.
It enhances communication between healthcare providers, including pharmacists, through eHR systems which helps in continuity of care and medication management.
Electronic Prescribing System
Electronic prescribing system allows healthcare professionals to enter medication orders electronically, minimizing errors related to handwriting and transcription.
Built in database allows a prompt system to identify and flag potential drug interactions and allergies when prescribing, improving medication safety.
Potential errors such as therapeutic duplication can be prevented.
Unit dose packaging machine
A unit dose packaging machine is an automated system that individually packages patient's medications in single doses.
Each dose is sealed in a blister pack or pouch, clearly labelled with essential information.
Advantages:
Accurate dosing
Medication Identification
Enhanced Medication adherence
Streamlined Medication Distribution
(Swisslog Inspire, n.d.)
Barcode Medication Administration (BCMA)
BCMA is a technology that involves scanning barcodes on medications and patient wristbands to ensure the "Five Rights" of medication administration: right patient, right medication, right dose, right route, and right time.
This technology reduces medication administration errors by verifying the medication's accuracy at the bedside.
BCMA systems are commonly used in hospitals and long-term care facilities, and they improve documentation accuracy by recording each administration electronically.
Medication Management Apps (e.g. HAGo)
Medication management apps includes mobile applications designed to help patients manage their medications effectively.
They maintain personal health records, including medication lists and dosages, which can be shared with healthcare providers.
These apps may send medication reminders and notifications to users' smartphones to ensure they take their medications as prescribed.
Medication management apps can also provide educational resources and drug interaction information.
2. Medication Delivery Services
Medication delivery refers to the process of delivering prescribed medications to patients, typically to their homes, long-term care facilities, or other remote locations.
It has gained significant importance, especially during the COVID-19 pandemic, as it reduces the need for in-person visits to hospitals and pharmacies, ensuring patient safety.
Enhanced Adherence: Medication delivery services ensure that patients have a continuous supply of their medications, reducing the risk of missed doses and medication-related errors.
Reduced In-Person Contact: During public health crises like pandemics, medication delivery minimizes the need for patients to visit hospital/ pharmacies, decreasing their exposure to potential sources of infection.
Improved Medication Access: Medication delivery helps patients, especially those with limited mobility, gain easier access to their prescribed medications, promoting medication safety by reducing the risk of medication mismanagement.
Medication Accuracy: Automated prescription dispensing machines used in healthcare facilities for medication delivery reduce human error, ensuring accurate medication doses are delivered to patients.
Patient Convenience: The convenience of having medications delivered to one's doorstep can lead to better medication adherence, thereby improving safety.
3. Telepharmacy Services
Telepharmacy Services involve the remote provision of Pharmacy Services by Pharmacists using telecommunications technology.
Medication Review: Through telepharmacy, pharmacists can remotely review patients' medication regimens, ensuring the appropriateness of prescribed medications and minimizing the risk of medication-related problems.
Medication Counseling: Pharmacists can counsel patients via telepharmacy, educating them about medication use, potential side effects, and proper administration, which enhances medication safety by promoting proper drug utilization.
Access to Expertise: Telepharmacy ensures that even patients in remote or underserved areas have access to expert pharmacy care, reducing the risk of medication errors due to a lack of pharmacy services.
Timely Intervention: Telepharmacy facilitates timely intervention by pharmacists in case of potential medication issues, such as adverse drug reactions or interactions, contributing to medication safety.
Continuity of Care: Patients receiving telepharmacy services benefit from regular interactions with pharmacists, which can lead to improved medication adherence and better patient safety.
4. Primary Healthcare resources
Community Pharmacy and Pharmacists
Community Pharmacists are essential members of the healthcare team who play a vital role in promoting medication safety within the community.
Their services extend beyond simply dispensing medications; they are often accessible and trusted healthcare professionals who provide critical services to enhance medication safety.
Community Chain pharmacies in Hong Kong include Mannings and Watsons. There are also NGOs pharmacies, such as:
Medication Counseling: Community Pharmacists offer personalized medication counseling, ensuring that patients understand their medications, including proper dosages, administration, potential side effects, and interactions.
Medication Reviews: Pharmacists conduct medication reviews to identify and resolve issues like drug interactions, duplications, and potential adverse effects.
They also aim to optimize medication regimens, especially for patients with chronic conditions, focusing on enhancing medication safety.
Adherence Support: Pharmacists help improve patient adherence by identifying barriers and suggesting strategies to overcome them.
Immunizations: Community Pharmacists may provide vaccinations, contributing to public health by preventing medication-related diseases.
Over-the-Counter (OTC) Guidance: They offer advice on the safe use of OTC medications and dietary supplements.
Health Education: Community Pharmacists educate patients on health and medication-related topics, further promoting medication safety.
Support Groups
Support groups provide a platform for patients to share their experiences, challenges, and strategies for managing their conditions and medications.
Collaborative Care Models and Co-Care
The Society of Hospital Pharmacists of Hong Kong (SHPHK)
The SHPHK provides the latest drug news and discussion on different health topics.
The Drug Education Resources Centre, DERC also publishes articles to educate the general public on some commonly used medications and vaccines.
Medication Safety Technology Challenges
Integration Challenges: Implementing medication safety technologies like eHR or BCMA systems can be technically complex and costly.
User Adoption: Ensuring that healthcare providers and staff are proficient in using these technologies can be a significant challenge.
Data Security Concerns: Safeguarding patient information and data is paramount but can be challenging due to the ever-evolving landscape of cybersecurity threats.
Patient Engagement Challenges and Limitations
Health Literacy: Low health literacy among some patient populations can hinder their understanding of medication instructions, potentially leading to errors.
Cultural and Language Barriers: Patients from diverse cultural backgrounds may face language barriers, making it challenging to comprehend medication instructions.
Socioeconomic Factors: Patients facing financial hardship may struggle to afford medications, leading to non-adherence and medication-related issues.
Conclusion
Proper storage of medications is essential to maintain their potency and ensure patient safety.
Patients should always read and follow the storage instructions on medication labels and consult with a pharmacist or healthcare professional when in doubt.
The use of smart technological solutions and community engagement are essential for a safer and more effective healthcare system.
Collaboration between Primary Healthcare providers and community resources can foster a sustainable pharmaceutical care and better health outcomes.
Chui, M. A., Pohjanoksa-Mäntylä, M., & Snyder, M. E. (2019). Improving medication safety in varied health systems. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2019.04.012
Gil-Candel, M., Solana‐Altabella, A., Vicente-Escrig, E., Puplá-Bartoll, A., Azuara, J. B., Pérez-Huertas, P., & Piqueres, R. F. (2023). Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results. European Journal of Hospital Pharmacy, 30(2), 107–112. https://doi.org/10.1136/ejhpharm-2021-003194
Hänninen, K., Ahtiainen, H. K., Suvikas-Peltonen, E., & Tötterman, A. M. (2023). Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review. European Journal of Hospital Pharmacy, 30(3), 127–135. https://doi.org/10.1136/ejhpharm-2021-003002
Jafarzadeh, A., Mahboub‐Ahari, A., Najafi, M., Yousefi, M., & Dalal, K. (2021). Medicine storage, wastage, and associated determinants among urban households: a systematic review and meta-analysis of household surveys. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11100-4
Kavanagh, O. N., Courtenay, A. J., Khan, F., & Lowry, D. (2022). Providing pharmaceutical care remotely through medicines delivery services in community pharmacy. Exploratory Research in Clinical and Social Pharmacy, 8, 100187. https://doi.org/10.1016/j.rcsop.2022.100187
Lee, S., & Schommer, J. C. (2022). Medication use and storage, and their potential risks in US households. Pharmacy, 10(1), 27. https://doi.org/10.3390/pharmacy10010027
Mash, R., Schouw, D., Daviaud, E., Besada, D., & Roman, D. (2022). Evaluating the implementation of home delivery of medication by community health workers during the COVID-19 pandemic in Cape Town, South Africa: a convergent mixed methods study. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07464-x
Mulac, A., Mathiesen, L., Taxis, K., & Granås, A. G. (2021). Barcode medication administration technology use in hospital practice: a mixed-methods observational study of policy deviations. BMJ Quality & Safety, 30(12), 1021–1030. https://doi.org/10.1136/bmjqs-2021-013223
Santos, Y. S., De Souza Ferreira, D., De Oliveira Silva, A. B. M., Da Silva Nunes, C. F., De Souza Oliveira, S. A., & Da Silva, D. T. (2023). Global overview of pharmacist and community pharmacy actions to address COVID-19: A scoping review. Exploratory Research in Clinical and Social Pharmacy, 10, 100261. https://doi.org/10.1016/j.rcsop.2023.100261
The videos in this course provide information for educational purposes only. The videos do not provide medical recommendations or diagnoses and are not substitutes for medical advice. It is crucial that you talk with your healthcare providers to discuss any questions you may have and seek them for medical advice, before you make any medical decisions. We will not be responsible for any decisions you will make or consequences you will have based on the information provided.
None of The Hong Kong Jockey Club Charities Trust, The Hong Kong Jockey Club, their respective affiliates or any other person involved in or related to the compilation of the contents herein (collectively, "the HKJC Parties") makes any express or implied warranties or representations with respect to the accuracy, timeliness or completeness of the contents or as to the results that may be obtained by the use thereof. In no event shall any HKJC Party have any liability of any kind to any person or entity arising from or related to any actions taken or not taken as a result of any of the contents herein.